• Latest Earnings
  • Equities
    Stock Analysis
    Stock Movers
    Deals
    Gainers And Losers
  • IPOs
  • Technology
    Artificial Intelligence
  • Web Stories
  • Benzinga Inspire

    Mankind Pharma

    This Pharma Giant's Shares Are Up After Jefferies Sees 16% Upside On The Back Of Expanding US ExportsThe company reported a significant 62.3% increase in its profit after tax (PAT) for Q4FY24, rising to ₹477 crores from ₹294 crores in the same quarter the previous year.
    Mankind Pharma: Strong Q4, Acquisition Reports Not Enough To Power Stock
    Why Mankind Pharma Shares Are Climbing Over 5% Today
    This Pharma Giant's Shares Are Up After Jefferies Sees 16% Upside On The Back Of Expanding US Exports
    Mankind Pharma: Strong Q4, Acquisition Reports Not Enough To Power Stock
    Why Mankind Pharma Shares Are Climbing Over 5% Today
    Mankind Pharma Shares Gain After Handy Beat On Q3 Profit Estimates
    |The company's domestic revenue had faced challenges due to factors such as the slowest monsoon since 2018 and increased precautions amid the waning of the Covid-19 pandemic.
    Why Mankind Pharma Shares Are Crashing Nearly 4% Today
    |Five private equity funds are reportedly considering a stake reduction in Mankind Pharma through a block deal.
    • Terms & Conditions
    • Do Not Sell My Personal Data/Privacy Policy
    • Disclaimer
    © 2025 Benzinga | All Rights Reserved